2018
DOI: 10.1016/b978-0-444-64189-2.00010-x
|View full text |Cite
|
Sign up to set email alerts
|

Spinocerebellar ataxias

Abstract: There are over 40 autosomal dominant spinocerebellar ataxias (SCAs) now identified. In this chapter we delineate the phenotypes of SCAs 1-44 and dentatorubral-pallidoluysian atrophy (DRPLA) and highlight the clinical and genetic features of the well characterised SCAs in detail in the main section of the chapter, along with their frequency and age at onset. We have included a section on the key phenotypic features of rare spinocerebellar ataxias and discuss rare and unusual presentations and genetic mechanisms… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 57 publications
(37 citation statements)
references
References 343 publications
0
36
0
Order By: Relevance
“…They may not be comprehensively covered by some next-generation sequencing panels and include the spinocerebellar ataxias, autosomal recessive ataxias, spastic ataxias, demyelinating and hypomyelinating leukodystrophies, and other rare metabolic and neurodegenerative disorders (table 2). [46][47][48][49][50][51][52][53] Several of the diseases in these groups, such as SCA1 (ATXN1), SCA3 (ATXN3), and Friedreich's ataxia (FXN) are triplet repeat disorders and may not therefore be covered by gene panels, even if they are extended to include wider groups of monogenic diseases associated with spasticity. [54][55][56] Particular attention should however be given to atypical presentations of treatable diseases in which lower limb spasticity occurs, often in the context of other clinical features, in the absence of T2-weighted imaging abnormalities in the spinal cord.…”
Section: Genetic Testingmentioning
confidence: 99%
“…They may not be comprehensively covered by some next-generation sequencing panels and include the spinocerebellar ataxias, autosomal recessive ataxias, spastic ataxias, demyelinating and hypomyelinating leukodystrophies, and other rare metabolic and neurodegenerative disorders (table 2). [46][47][48][49][50][51][52][53] Several of the diseases in these groups, such as SCA1 (ATXN1), SCA3 (ATXN3), and Friedreich's ataxia (FXN) are triplet repeat disorders and may not therefore be covered by gene panels, even if they are extended to include wider groups of monogenic diseases associated with spasticity. [54][55][56] Particular attention should however be given to atypical presentations of treatable diseases in which lower limb spasticity occurs, often in the context of other clinical features, in the absence of T2-weighted imaging abnormalities in the spinal cord.…”
Section: Genetic Testingmentioning
confidence: 99%
“…Spinocerebellar ataxia type 5 (SCA5) is characterized by a slowly progressive ataxia mainly affecting the cerebellum [1]. The mean age at onset is 33 years and is predominantly an adult onset ataxia.…”
Section: Introductionmentioning
confidence: 99%
“…Yet, infantile and childhood onset has been described in many spinocerebellar ataxias, including SCA2, SCA7, SCA10, SCA13, SCA14, SCA21, SCA25, SCA28, SCA29, SCA42, SCA44, and dentatorubral-pallidoluysian atrophy. 68,69 Some cases can be explained by the phenomenon of anticipation, with earlier onset and more severe presentation in subsequent generations that is typical of expansion-repeat disorders. 68 In the uncommon situation of autosomal dominant ataxia presenting in childhood, the phenotype tends to be more severe and complex than pure ataxia.…”
Section: Autosomal Dominant Ataxiasmentioning
confidence: 99%